Design and Evaluate Polymeric Micelles Loaded with Paclitaxel, A Chemotherapy Drug, for Breast Cancer Treatment
International Journal of Drug Delivery Technology · 25.12.2025 · 15 (04)
DOI: 10.25258/ijddt.15.4.43 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.12.2025. Verfasst von Diksha Joshi und 5 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Breast cancer, particularly the aggressive triple-negative subtype (TNBC), remains a major therapeutic challenge due to a lack of targetable receptors and the severe limitations of conventional chemotherapy. Paclitaxel (PTX) is a cornerstone drug, but its clinical utility is hampered by poor aqueous solubility and severe side effects linked to its solubilizing vehicle, Cremophor® EL. This study aimed to develop a Cremophor-free, polymeric nanoparticle system to improve the delivery and therapeutic profile of PTX. Paclitaxel was encapsulated within poly (lactic-co-glycolic acid) (PLGA) nanoparticles using a double-emulsion solvent evaporation method, with polyvinyl alcohol (PVA) as a stabilizer. The optimized formulation (NP3) exhibited a high encapsulation efficiency (84.25%), a particle size of ~309 nm, a negative zeta potential, and a spherical morphology as confirmed by FESEM and TEM. FTIR and DSC studies confirmed the absence of chemical interactions and the crystalline state of the encapsulated drug. In vitro release studies demonstrated a sustained release profile over 30 days, fitting the Korsmeyer-Peppas model. Crucially, the NP3 formulation showed significantly enhanced cytotoxicity against HepG2 and Huh-7 liver cancer cell lines compared to free PTX and a commercial formulation, while blank nanoparticles were non-toxic. The results indicate that PLGA-based nanoparticulate delivery is a promising strategy to solubilize PTX without harmful excipients, provide controlled release, and enhance its anticancer efficacy, offering a potential improved therapeutic option for challenging cancers like TNBC.
Zitieren
APA
Joshi, D., Hirvey, H., Budarapu, D., Dhar, C. C., Kapoor, B., & Maithili, T. (2025). Design and Evaluate Polymeric Micelles Loaded with Paclitaxel, A Chemotherapy Drug, for Breast Cancer Treatment. International Journal of Drug Delivery Technology, 15(04). https://doi.org/10.25258/ijddt.15.4.43
Vancouver
Joshi D, Hirvey H, Budarapu D, Dhar CC, Kapoor B, Maithili T. Design and Evaluate Polymeric Micelles Loaded with Paclitaxel, A Chemotherapy Drug, for Breast Cancer Treatment. International Journal of Drug Delivery Technology. 2025;15(04). doi:10.25258/ijddt.15.4.43
BibTeX
@article{Joshi2025,
author = {Joshi, Diksha and Hirvey, Himani and Budarapu, Divya and Dhar, Chaynika C. and Kapoor, Bhawana and Maithili, T.},
title = {Design and Evaluate Polymeric Micelles Loaded with Paclitaxel, A Chemotherapy Drug, for Breast Cancer Treatment},
journal = {International Journal of Drug Delivery Technology},
year = {2025},
volume = {15},
number = {04},
doi = {10.25258/ijddt.15.4.43}
}
EUVIMED